RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ASND
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Ascendis Pharma A/S as stock downgraded to Sell Candidate.
(Updated on Jul 03, 2024)

Sell candidate since Jul 03, 2024 PDF

The Ascendis Pharma A/S stock price fell by -1.53% on the last day (Wednesday, 3rd Jul 2024) from $136.27 to $134.18. During the last trading day the stock fluctuated 2.82% from a day low at $133.02 to a day high of $136.77. The price has risen in 6 of the last 10 days and is up by 8.92% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -95 thousand shares and in total, 148 thousand shares were bought and sold for approximately $19.83 million.

The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $133.41, a level that may pose a second chance to hit a runner. According to fan-theory $154.23 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ASND Signals & Forecast

The Ascendis Pharma A/S stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $134.95. On a fall, the stock will find some support from the long-term average at approximately $130.44. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 06, 2024, and so far it has fallen -3.12%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Ascendis Pharma A/S stock

Ascendis Pharma A/S finds support from accumulated volume at $131.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.75 between high and low, or 2.82%. For the last week, the stock has had daily average volatility of 3.36%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ASND) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Ascendis Pharma A/S to open at $134.66, and during the day (based on 14 day Average True Range), to move between $129.20 and $139.16, which gives a possible trading interval of +/-$4.98 (+/-3.71%) up or down from last closing price. If Ascendis Pharma A/S takes out the full calculated possible swing range there will be an estimated 7.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $135.10 (0.69%) than the support at $131.14 (2.27%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ascendis Pharma A/S stock A Buy?

Ascendis Pharma A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.717 Sell Candidate Downgraded

Predicted Opening Price for Ascendis Pharma A/S of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$134.66 ( 0.355%) $134.18

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ASND

Fibonacci Support & Resistance Levels

Level Price
R3 138.41 3.15%
R2 136.97 2.08%
R1 136.09 1.42%
Price 134.18
S1 133.22 -0.712%
S2 132.34 -1.37%
S3 130.91 -2.44%

Accumulated Volume Support & Resistance Levels

Level Price
R3 137.20 2.25%
R2 135.79 1.20%
R1 135.10 0.686%
Price 134.18
S1 131.14 -2.27%
S2 124.82 -6.98%
S3 124.04 -7.56%

FAQ

What is the symbol for Ascendis Pharma A/S Stock and on which exchange is it traded?
The symbol for Ascendis Pharma A/S is ASND and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ascendis Pharma A/S Stock?
Ascendis Pharma A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Ascendis Pharma A/S Stock?
Ascendis Pharma A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ascendis Pharma A/S Stock.

What's the current price of Ascendis Pharma A/S Stock?
As of the end of day on the Jul 03, 2024, the price of an Ascendis Pharma A/S (ASND) share was $134.18.

What is the 52-week high and low for Ascendis Pharma A/S Stock?
The 52-week high for Ascendis Pharma A/S Stock is $161.00 and the 52-week low is $85.29.

What is the market capitalization of Ascendis Pharma A/S Stock?
As of the Jul 03, 2024, the market capitalization of Ascendis Pharma A/S is 7.597B.

When is the next earnings date for Ascendis Pharma A/S?
The upcoming earnings date for Ascendis Pharma A/S is Sep 03, 2024.
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT